Medpace Holdings, Inc.

Medpace Holdings, Inc. is a leading global contract research organization specializing in providing comprehensive clinical research-based drug and medical device development services. Established in 1992 and headquartered in Cincinnati, Ohio, the company partners closely with pharmaceutical, biotechnology, and medical device firms to facilitate the execution of clinical trials across all development phases, from Phase I through Phase IV. Medpace delivers a full-service and integrated model that encompasses clinical trial design, project management, central laboratory services, regulatory affairs, data management, pharmacovigilance, as well as bioanalytical laboratory, human pharmacology, imaging, and electrocardiography support. With a workforce of approximately 5,900 employees and a presence spanning North America, Europe, and Asia, Medpace leverages scientific, regulatory, and therapeutic expertise to streamline clinical development, enhance trial quality, and accelerate the path from discovery to market for new therapies. The company plays a significant role in advancing innovation within the healthcare, biotechnology, and pharmaceutical sectors, supporting clients with efficient, high-quality outsourced clinical development solutions.